Research Advisory Council (RAC)


PCC is advised and counseled by a Research Advisory Council (RAC) that comprises prominent prostate cancer researchers. The role of RAC is to:
  • Synthesize the results of the peer review process and make recommendations for funding to senior PCC staff
  • Receive reports of the evaluation of PCC research programs and provide advice on the development of new programs and the ongoing improvements to existing programs
  • Lead the identification of strategic research areas that could be targeted with specific Requests For Applications
  • Evaluate the PCC peer review processes and recommend necessary enhancements on an ongoing basis
  • Recommend membership of peer review panels
  • Identify potential national and international opportunities for collaboration
  • Provide advice in the development and refinements of scientific and administrative policies
The Council will be composed of established prostate cancer researchers who:
  • Collectively represent expertise in all areas of prostate cancer research
  • Are broadly representative of all major regions in Canada
  • Individually have a strong track record in peer-reviewed research funding and research output
In addition, the Council will include 2 non-scientific members, one of whom must be a prostate cancer patient or survivor. Each will be identified and selected through a formal nomination process.

Current Membership

Alison Allan,Western University, London, ON
David Berman, Queen's Cancer Research Institute, Kingston, ON
Paul Boutros, Ontario Institute for Cancer Research (OICR), Toronto
, ON
Ralph Buttyan, Vancouver Prostate Centre, Vancouver, BC
Kim Chi, BC Cancer Agency, Vancouver, BC
Michael Cox, University of British Columbia, Vancouver, BC

Stuart Edmonds (Ex Officio), Prostate Cancer Canada, Toronto, ON
Masoom Haider, Mount Sinai Hospital, Toronto, ON
Anne Katz, Manitoba Prostate Centre, Winnipeg, MB
Winston Klass, Community Representative, Concord, ON
John Lewis, University of Alberta, Edmonton, AB
Mathieu Lupien, Princess Margaret Cancer Centre, Toronto, ON
Randy Mellow, Community Representative, Peterborough, ON

Cynthia Ménard, Centre hospitalier de l'Université de Montréal, Montreal, QC
Ian G.Mills, Queen's University Belfast, Belfast, UK
Fred Saad, Université de Montréal, Montreal, QC
Gurmit Singh (Scientific Chair), McMaster University, Hamilton, ON

Danny Vesprini, Sunnybrook Research Institute, Toronto, ON
Katherine Zukotynski, McMaster University, Hamilton, ON

As of June 28, 2018

 


 





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada launches first national program in radionuclide therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More

Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More


Click here for news archive